For the past three years, biotechs and pharmas have renamed, rebranded and more in a bid to refresh their corporate appeal. ...

The fine chemical sector in Europe is witnessing a notable transformation, primarily fueled by the pharmaceutical industry ...

New York, USA, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Market Overview: The market for Zollinger-Ellison syndrome treatment is on a ...

(Alliance News) - GSK PLC on Thursday said its Blenrep drug has shown overall survival benefits in patients with relapsed or refractory multiple myeloma, the third most common type of blood cancer.

Larsen & Toubro Ltd. key Products/Revenue Segments include Income From Construction Work, Income from Manufacturing and Trading Activities, Other Services, Other Operating Revenue, Property ...